Screening efficacy of PhA and MNA-SF in different stages of sarcopenia in the older adults in community
Abstract Objective To compare the screening ability of the phase Angle (PhA) and the Short-Form Mini Nutritional Assessment (MNA-SF) alone and combined detection in the different stages of sarcopenia among the older adults in the community. Methods The older adults aged 65 and above were enlisted du...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | BMC Geriatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12877-022-03716-x |
_version_ | 1797952368468295680 |
---|---|
author | Xiaoli Zhu Xinying Dong Li Wang Xueting Lao Shugang Li Hao Wu |
author_facet | Xiaoli Zhu Xinying Dong Li Wang Xueting Lao Shugang Li Hao Wu |
author_sort | Xiaoli Zhu |
collection | DOAJ |
description | Abstract Objective To compare the screening ability of the phase Angle (PhA) and the Short-Form Mini Nutritional Assessment (MNA-SF) alone and combined detection in the different stages of sarcopenia among the older adults in the community. Methods The older adults aged 65 and above were enlisted during community outpatient service and their nutritional status was evaluated by MNA-SF scale. PhA was measured by bioelectrical impedance analysis (BIA). AWGS2019 and EWGSOP2010 were used to define the different stages of sarcopenia. We measured skeletal mass index (SMI) and grip strength with BIA and electronic grip apparatus and measured body function with 6-m pace, SPPB test, and standing test. Results The AUC of PhA in the screening of possible sarcopenia was 0.640, the sensitivity was 58.49%, the specificity was 66.67%, and the cut-off value was 4.5. The AUC of the combined PhA and MNA-SF for possible sarcopenia was 0.642, the sensitivity was 57.55%, and the specificity was 70.00%. The AUC of MNA-SF for the screening of pre-sarcopenia was 0.805, the sensitivity was 66.67%, the specificity was 85.83%, and the cut-off value was 12. The AUC of the combined PhA and MNA-SF was 0.826, the sensitivity was 75.00%, and the specificity was 85.00%. The AUC of PhA in the screening of sarcopenia (common type) was 0.808, the sensitivity was 82.35%, the specificity was 73.33%, the cut-off value was 4.4. The AUC of the combined PhA and MNA-SF for sarcopenia (common type) was 0.835, the sensitivity was 76.47% and the specificity was 81.67%. The AUC of PhA and for the screening of severe sarcopenia was 0.935, the sensitivity was 93.33%, the specificity was 92.50%, and the cut-off value was 4.1. The AUC of the combined PhA and MNA-SF was 0.943, the sensitivity was 86.67%, and the specificity was 93.33%. Conclusion The screening ability of PhA alone or in combination was higher than that of MNA-SF in the screening of possible sarcopenia. The screening ability of the combined detection was higher than that of PhA alone in the screening of pre-sarcopenia. The combination of PhA and MNA-SF or PhA alone all performed better value in the screening of sarcopenia (common type). Compared to MNA-SF, the PhA performed better in the screening of severe sarcopenia, which provided references for identifying patients with different stages of sarcopenia in the community. |
first_indexed | 2024-04-10T22:46:17Z |
format | Article |
id | doaj.art-b3782e33dd2c4ccfbd74e7a569662db9 |
institution | Directory Open Access Journal |
issn | 1471-2318 |
language | English |
last_indexed | 2024-04-10T22:46:17Z |
publishDate | 2023-01-01 |
publisher | BMC |
record_format | Article |
series | BMC Geriatrics |
spelling | doaj.art-b3782e33dd2c4ccfbd74e7a569662db92023-01-15T12:20:56ZengBMCBMC Geriatrics1471-23182023-01-0123111310.1186/s12877-022-03716-xScreening efficacy of PhA and MNA-SF in different stages of sarcopenia in the older adults in communityXiaoli Zhu0Xinying Dong1Li Wang2Xueting Lao3Shugang Li4Hao Wu5Department of Child, Adolescent Health and Maternal Care, School of Public Health, Capital Medical UniversityDepartment of Child, Adolescent Health and Maternal Care, School of Public Health, Capital Medical UniversityFangzhuang Community Health Center, Capital Medical UniversityFangzhuang Community Health Center, Capital Medical UniversityDepartment of Child, Adolescent Health and Maternal Care, School of Public Health, Capital Medical UniversitySchool of general practice and continuing education, Capital Medical UniversityAbstract Objective To compare the screening ability of the phase Angle (PhA) and the Short-Form Mini Nutritional Assessment (MNA-SF) alone and combined detection in the different stages of sarcopenia among the older adults in the community. Methods The older adults aged 65 and above were enlisted during community outpatient service and their nutritional status was evaluated by MNA-SF scale. PhA was measured by bioelectrical impedance analysis (BIA). AWGS2019 and EWGSOP2010 were used to define the different stages of sarcopenia. We measured skeletal mass index (SMI) and grip strength with BIA and electronic grip apparatus and measured body function with 6-m pace, SPPB test, and standing test. Results The AUC of PhA in the screening of possible sarcopenia was 0.640, the sensitivity was 58.49%, the specificity was 66.67%, and the cut-off value was 4.5. The AUC of the combined PhA and MNA-SF for possible sarcopenia was 0.642, the sensitivity was 57.55%, and the specificity was 70.00%. The AUC of MNA-SF for the screening of pre-sarcopenia was 0.805, the sensitivity was 66.67%, the specificity was 85.83%, and the cut-off value was 12. The AUC of the combined PhA and MNA-SF was 0.826, the sensitivity was 75.00%, and the specificity was 85.00%. The AUC of PhA in the screening of sarcopenia (common type) was 0.808, the sensitivity was 82.35%, the specificity was 73.33%, the cut-off value was 4.4. The AUC of the combined PhA and MNA-SF for sarcopenia (common type) was 0.835, the sensitivity was 76.47% and the specificity was 81.67%. The AUC of PhA and for the screening of severe sarcopenia was 0.935, the sensitivity was 93.33%, the specificity was 92.50%, and the cut-off value was 4.1. The AUC of the combined PhA and MNA-SF was 0.943, the sensitivity was 86.67%, and the specificity was 93.33%. Conclusion The screening ability of PhA alone or in combination was higher than that of MNA-SF in the screening of possible sarcopenia. The screening ability of the combined detection was higher than that of PhA alone in the screening of pre-sarcopenia. The combination of PhA and MNA-SF or PhA alone all performed better value in the screening of sarcopenia (common type). Compared to MNA-SF, the PhA performed better in the screening of severe sarcopenia, which provided references for identifying patients with different stages of sarcopenia in the community.https://doi.org/10.1186/s12877-022-03716-xCommunityThe older adultsSarcopeniaThe phase angleMNA-SF |
spellingShingle | Xiaoli Zhu Xinying Dong Li Wang Xueting Lao Shugang Li Hao Wu Screening efficacy of PhA and MNA-SF in different stages of sarcopenia in the older adults in community BMC Geriatrics Community The older adults Sarcopenia The phase angle MNA-SF |
title | Screening efficacy of PhA and MNA-SF in different stages of sarcopenia in the older adults in community |
title_full | Screening efficacy of PhA and MNA-SF in different stages of sarcopenia in the older adults in community |
title_fullStr | Screening efficacy of PhA and MNA-SF in different stages of sarcopenia in the older adults in community |
title_full_unstemmed | Screening efficacy of PhA and MNA-SF in different stages of sarcopenia in the older adults in community |
title_short | Screening efficacy of PhA and MNA-SF in different stages of sarcopenia in the older adults in community |
title_sort | screening efficacy of pha and mna sf in different stages of sarcopenia in the older adults in community |
topic | Community The older adults Sarcopenia The phase angle MNA-SF |
url | https://doi.org/10.1186/s12877-022-03716-x |
work_keys_str_mv | AT xiaolizhu screeningefficacyofphaandmnasfindifferentstagesofsarcopeniaintheolderadultsincommunity AT xinyingdong screeningefficacyofphaandmnasfindifferentstagesofsarcopeniaintheolderadultsincommunity AT liwang screeningefficacyofphaandmnasfindifferentstagesofsarcopeniaintheolderadultsincommunity AT xuetinglao screeningefficacyofphaandmnasfindifferentstagesofsarcopeniaintheolderadultsincommunity AT shugangli screeningefficacyofphaandmnasfindifferentstagesofsarcopeniaintheolderadultsincommunity AT haowu screeningefficacyofphaandmnasfindifferentstagesofsarcopeniaintheolderadultsincommunity |